Publications by authors named "Nikola Hanhoff"

Claim this Profile
S
Socio-demographic and psycho-social determinants of HIV late presentation in Germany - results from the FindHIV study.
Paul Lauscher, Nikola Hanhoff, Frederik Valbert, Knud Schewe, Christine Koegl

AIDS Care· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections].
Daniel Schmidt, Christian Kollan, Knud Schewe, Nikola Hanhoff, Robin Rüsenberg

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
Daniel Schmidt, Christian Kollan, Barbara Bartmeyer, Viviane Bremer, Tim Schikowski, Nikola Hanhoff

Infection· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and avoiding late presentation for HIV diagnosis - study protocol of a trial using mixed methods (FindHIV).
Frederik Valbert, Eva Wolf, Stefan Preis, Sven Schellberg, Knud Schewe, Nikola Hanhoff

AIDS Care· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study.
Frederik Valbert, Eva Wolf, Knud Schewe, Stephan Klauke, Nikola Hanhoff

Value Health· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of three decades of antiretroviral therapy in a longitudinal population cohort study.
Nikola Hanhoff, Quang Vu, Raynell Lang, M John Gill

Antivir Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration.
Suzanne M Ingle, Heidi M Crane, Tracy R Glass, Benita Yip, Viviane D Lima, Nikola Hanhoff

J Clin Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV.
Christoph D Spinner, Nikola Hanhoff, Ivanka Krznaric, Gaby Knecht, Tim Kuemmerle

Infection· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Cornelia Feiterna-Sperling, Christoph Königs, Gundula Notheis, Bernd Buchholz, Renate Krüger, Nikola Hanhoff

Med Microbiol Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.
Leonie Meemken, Nikola Hanhoff, Alice Tseng, Stefan Christensen, Anton Gillessen

Ann Pharmacother· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study.
Sarah Mostardt, Nikola Hanhoff, Jürgen Wasem, Armin Goetzenich, Knud Schewe

Eur J Health Econ· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis